Week 16: Closing Out 1.7mg
The fourth and final week at 1.7mg under the standard schedule. This is the natural moment to take stock — review progress, confirm tolerability, and decide whether the next step is 2.4mg, another month at 1.7mg, or something else.
Week 16 is the final week of the 1.7mg block. The standard Wegovy schedule moves to 2.4mg at week 17, but that is a recommendation, not a requirement. Plenty of people stay at 1.7mg as a maintenance dose if the response has been good and the side effects are mild. This week is the natural time to think about which path makes sense.
The injection itself is routine by now — fourth shot at this dose, no expected drama. The bigger work of week 16 is data gathering. Weight trend over the four weeks at 1.7mg, side effect log, energy notes, habit observations. Anything that helps you and your prescriber make a real decision rather than a default one.
Appetite Suppression
Reliable, often deep suppression by the end of the 1.7mg block. The next titration tends to push it further; some users find 1.7mg already sufficient.
Loss usually continues at a steady pace through the end of the 1.7mg block, though some users see early signs of plateauing.
The Week 16 Timeline
The Week 16 Timeline
Day 106 (Injection 16)
Final 1.7mg Dose
If you titrate next week, this is your last 1.7mg injection. Confirm the next pen and the new dose with your prescriber before the appointment.
Days 108-110
Four-Month Review
Pull together weight, measurements, side effect notes, and habit shifts from the entire 1.7mg block. The trend matters more than any single week.
Day 112
Titration Decision
Step up to 2.4mg, hold at 1.7mg, or step back. All are valid depending on response and tolerability. The right call is the one that fits your situation, not the schedule.
Navigating Symptoms
If side effects have been well-controlled for the past two weeks, the next titration is more likely to feel manageable. Persistent issues at 1.7mg are worth raising before stepping up.
What to focus on this week is the honest comparison. Is the suppression at 1.7mg doing what you need? Are the habits sticking? Is the side effect picture sustainable? If the answer to all three is yes, the case for stepping up is mostly about extra benefit; if any answer is shaky, the case for holding is stronger.
The standard schedule exists because it works for most people in trials. It does not exist because it is the only valid path. Some users do well long-term at 1.0mg, some at 1.7mg, some need 2.4mg. The dose that works is the one that produces meaningful results with tolerable side effects, which is rarely something you can predict in advance.
What Users Report
“Closing out the 1.7mg month felt good. I'm down a meaningful amount, the side effects are mild, and I'm ready for the next step. My doctor and I agreed on 2.4mg.”
— Ryan B.
“We decided to stay at 1.7mg for another month. Loss has been steady, side effects are easy, and there is no reason to push the dose higher just because the schedule says so.”
— Mei K.
Looking ahead
Week 17 is the final titration step on the standard schedule — the jump to 2.4mg, the target dose. It is the last big adjustment phase before the long maintenance work begins. Going in with clean data and a clear plan makes the transition smoother.